Buy These 2 Breakout Stocks in the Market's Hottest Sector (The Market Cap)

Bret Jensen Reveals 2 High-Flying Small Cap Biotech Stocks

Ensure you continue to get this valuable content by whitelisting us (find out how here).

Monday, March 23, 2015 Edit Subscriber Profile  |  Unsubscribe  |  Privacy Policy

6 Unique Ways You Can Profit From The Marijuana Boom Market TerraTech, Medbox, GW Pharmaceuticals: these Pot Stocks made investors rich by offering them just ONE way to profit from Wall Street's cannabis craze. Now, imagine a pot company with SIX profit streams?! It exists! And 1,816% Gains Could Be YOURS! Learn How to Profit HERE!

FEATURE

Buy These 2 Breakout Stocks in the Market's Hottest Sector While stocks have been collectively flat thus far in 2015, one area of the market has outshined all others - small cap biotech. But if you want to reap the rewards, you must be patient and prepared. Having a biotech "insider" also helps. And Bret Jensen is just that. His subscribers have recently seen returns like 120% and 180% in a matter of months. Get two of Bret's favorite biotech growth stocks now. Click to read more

EDITOR'S PICKS Actionable Ideas: 2 Refiners Offer a Rare Bright Spot in Energy Sector Biotech Investing: 2 Biotech Stocks under $10 to Buy Now Simple Trick to Boost Monthly Income: Now You Can Get Paid Every Time Netflix Rents a Movie [ad] OUR TOP INVESTING IDEAS 2 MLPs to Reap Future American Energy Profits The current maladies in the energy sector are well publicized. Share prices are down, and nobody knows where oil will be trading tomorrow. But the future is still clear. America is working its way towards energy independence, and these two MLPs trading at bargain prices will be there to reap the profits. Click to read more Google Is Dead: This Stock Is the Next Google There's no denying Google's dominance since its 2004 IPO, but the end of this juggernaut's growth story is here. Investors looking for life-changing returns must look elsewhere, and the best place for growth is in biotech. New technologies are allowing for more drugs to be synthesized and approved faster than ever, and with a large and growing market, the profits will be massive. Click to read more

© Copyright 1998-2015, Investors Alley Corp. All rights reserved. See Privacy Policy and Terms of Use | Contact Us

          If you enjoyed reading this email, click here to forward it to a friend or colleague.

You are receiving this message because you registered ignoble.experiment@arconati.us through INO.com Invite Sell - Apr 2014.
Click here to send us comments or questions regarding this mailing. Unsubscribe/update profile using link below.

This message from Investors Alley Corp. is being sent in full accordance with the CAN-SPAM Act.
We respect your privacy and, therefore, this email was sent directly from Investors Alley.  Please review our Privacy Statement and Terms of Use. 
If you no longer wish to receive emails from Investors Alley, please opt-out using the link below.

The opinions in this email and corresponding web sites are neither an offer nor a recommendation to buy or sell any security. Investors Alley Corp. and its affiliates may hold a position in any of the companies mentioned.  Investors Alley Corp. is not a registered investment firm nor a broker/dealer.  We urge you to always conduct your own research and due diligence and obtain professional advice before making any investment decision.

All information contained herein is copyright 2015, Investors Alley Corp.
Investors Alley Corporation | 41 Madison Avenue | 31st Floor | New York, NY  10010

Update Your Profile Information | Modify Subscription Settings or Unsubscribe From Emails